| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2555020 | Life Sciences | 2006 | 9 Pages |
Abstract
Our data suggest that both anti-proliferative and anti-angiogenic activities in endothelial cells might account for the greater than expected beneficial effects of rosiglitazone for the treatment and prevention of atherosclerosis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Wayne Huey-Herng Sheu, Hsiu-Chung Ou, Fen-Pi Chou, Tsung-Min Lin, Ching-Hwa Yang,